D-161
Jump to navigation
Jump to search
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C25H27NO2 |
| Molar mass | 373.496 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
D-161[1] is a chemical known in research circles as a triple reuptake inhibitor. Although this compound has lent support to the inclusion of dopamine in the monoamine hypothesis of depression, D-161 has not been tested in clinical trials.
A more recent study was reported.[2]
A couple of patents are also disclosed.[3][4]
Synthesis
[edit | edit source]The synthesis of this agent has been reported.[5][6]
References
[edit | edit source]- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Aloke K. Dutta, WO2005105075 (Wayne State University).
- ^ Aloke K. Dutta, US8017791 (2011 to Wayne State University).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).